Prevention and Treatment of Bronchopulmonary Dysplasia (BPD) in Infants; Systematic Review

Abstract: Bronchopulmonary dysplasia (BPD) stays a major cause of mortality and morbidity in incredibly low birth weight (ELBW) babies and is associated with an increased danger for neurodevelopmental disability in later years. The purpose of this systematic review was to evaluate roles of prevention and determine the therapeutic approaches for Bronchopulmonary dysplasia among premature infants, we attended to overview the evidence based of most important studies about this topic. We conducted a search of the Cochrane database to evaluate the preventions medications and treatment for Bronchopulmonary dysplasia in newborn infants that were studied up to 2016. We used this list as MeSH terms or equivalent to compose searches of MEDLINE and EMBASE for all studies evaluating these medications and strategies for prevention bronchopulmonary dysplasia OR respiratory distress syndrome, newborn. We concluded The requirement for prolonged mechanical ventilation (more than 2 hours) may be an early marker for the advancement of BPD in preterm infants of more than 26 weeks GA. This association may assist to identify a target population with a high danger of BPD. Keywords: MEDLINE and EMBASE, Bronchopulmonary dysplasia (BPD). Title: Prevention and Treatment of Bronchopulmonary Dysplasia (BPD) in Infants; Systematic Review Author: Eman Ahmed Alshikh, Duaa Abdulrazaq Alshikh, Zahra Ali Alribh, Zainab Ali Ghallab, Fatimah Mohammed Alnemer International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Research Publish Journals

Citation